An overview of cardiac rehabilitation use plus interviews with Monica Mukherjee, MD, MPH, FACC, FASE and with Jonathan Ledyard, MS, RCEP.
The HEART Score is a safe risk-stratification tool for chest pain, but it does not seem to do much for reducing hospital utilization and admissions.
Accountable Care Organizations are taking more responsibility for healthcare management, record keeping, and payments.
Heart failure is the number 1 reason for patient re-admittance to acute-care facilities according to the American Heart Association.
Anticoagulation under- and overdoing can be problematic in patients with atrial fibrillation.
The link between non-steroidal anti-inflammatory drugs and risk for myocardial infarction has been found.
After the House of Representatives passed the American Health Care Act on May 4th, the true impact and cost of the plan remains unknown.
The repeal and replacement of the Affordable Care Act has stirred concern with a number of national health initiatives.
Pitavastatin had greater low-density lipoprotein-lowering effects than pravastatin.
An interview with David E. Newman-Toker, MD, PhD, on reducing the frequency of misdiagnoses.
An interview with Elise Barney, DO on sexism in the medical workplace.
Two new bills for the reform of existing medical liability laws have been brought to the United States Congress.
Fasting vs Nonfasting Lipid Values and Cardiovascular Risk: Q&A With Advisory Board Member, Eliot Brinton, MD
Eliot Brinton, MD, FAHA, FNLA, president and director of the Utah Lipid Center, discusses the benefits of fasting lipid profiles in predicting cardiovascular risk.
Antihypertensive use in the month prior to conception through the third month of pregnancy resulted in an increased risk for congenital heart defects.
The effects of alcohol consumption on cardiovascular disease were explored in a population-based study.
Experts weigh in on how to improve racial and ethnic disparities in cardiovascular health.
Medical malpractice expert Michelle Mello, JD, PhD, talks malpractice reform in a changing political landscape.
The transition process can be challenging for patients and families, requiring a great deal of preplanning by providers.
Results of the FOURIER trial, presented at the 2017 ACC Scientific Sessions, raise questions about the efficacy of PCSK9 inhibitors as long-term therapy for patients with atherosclerotic CVD.
A man presents to an urgent care clinic with radiating chest pain. What's the most likely diagnosis?
The Cardiology Advisor Articles
- Beta-Blockers Reduce CV Mortality in Heart Failure With Preserved Ejection Fraction
- Timing of BP Measurements in Orthostatic Hypotension Linked to Adverse Effects
- Hypertension, Diabetes in Midlife Increase Risk of Dementia
- Reduced GFR Associated With Increased Atrial Fibrillation Risk
- Biomarker-Based Model Predicts Mortalty in Coronary Heart Disease
- Assessing Chest Pain in ER With Short-term Risk Stratification Tool
- Cardiac Rehabilitation: Changes, Challenges, and Clinician Perspectives
- Shortness of Breath and Palpitations After a Funeral: Depression or Something Worse?
- Newly Diagnosed Atrial Fibrillation Benefits From Cardiology Care vs Primary Care
- Noncalcified, High-Risk Coronary Plaque Burden Increased With Psoriasis
- Case Study: Cardiac Manifestations of Rheumatoid Arthritis
- Preventing Venous Thromboembolism After Hip, Knee Arthoplasty: Comparing Anticoagulant Efficacy
- Patients Report Breakdowns in Hospital Care
- Evolocumab Added to Statin Therapy Does Not Affect Cognition
- Risk Stratification Using Platelet Aggregation in Stable CAD